Morten Agertoug Nielsen

Morten Agertoug Nielsen

Professor

Member of:

  • VAR2CSA team

ORCID: 0000-0003-2668-4992

Publication year:
All
1 - 10 out of 97Page size: 10
  1. 2024
  2. Published

    Molecular properties and diagnostic potential of monoclonal antibodies targeting cytotoxic α-synuclein oligomers

    Nielsen, J., Lauritsen, J., Pedersen, J. N., Nowak, J. S., Bendtsen, M. K., Kleijwegt, G., Lusser, K., Pitarch, L. C., Moreno, J. V., Schneider, M. M., Krainer, G., Goksøyr, L., Khalifé, P., Kaalund, S. S., Aznar, S., Kjærgaard, M., Sereikaité, V., Strømgaard, K., Knowles, T. P. J., Nielsen, M. A. & 3 others, Sander, Adam F. , Romero-Ramos, M. & Otzen, D. E., 2024, In: npj Parkinson's Disease. 10, 1, 26 p., 139.

    Research output: Contribution to journal › Journal article › Research › peer-review

  3. Published

    Tumor-agnostic cancer therapy using antibodies targeting oncofetal chondroitin sulfate

    Vidal-Calvo, E. E., Martin-Salazar, A., Choudhary, S., Dagil, R., Raghavan, S. S. R., Duvnjak, L., Nordmaj, M. A., Clausen, T. M., Skafte, A., Oberkofler, J., Wang, K., Agerbæk, M. Ø., Løppke, C., Jørgensen, A. M., Ropac, D., Mujollari, J., Willis, S., Garcias López, A., Miller, R. L., Karlsson, R. T. G. & 21 others, Goerdeler, Felix Tobias Reinhard, Chen, Yen-Hsi, Colaço, A. R., Wang, Y., Lavstsen, Thomas, Martowicz, A., Nelepcu, I., Marzban, M., Oo, H. Z., Ørum-Madsen, M. S., Wang, Y., Nielsen, Morten Agertoug, Clausen, Henrik, Wierer, M., Wolf, D., Gögenur, Ismail, Theander, Thor Grundtvig, Al-Nakouzi, N., Gustavsson, Tobias, Daugaard, M. & Salanti, Ali, 2024, In: Nature Communications. 15, 1, 20 p., 7553.

    Research output: Contribution to journal › Journal article › Research › peer-review

  4. 2023
  5. Published

    Aotus nancymaae model predicts human immune response to the placental malaria vaccine candidate VAR2CSA

    Doritchamou, J., Nielsen, M. A., Chêne, A., Viebig, N. K., Lambert, L. E., Sander, A. F., Semblat, J. P., Hundt, S., Orr-Gonzalez, S., Janitzek, C. M., Spiegel, A. J., Clemmensen, S. B., Thomas, M. L., Nason, M. C., Snow-Smith, M., Barnafo, E. K., Shiloach, J., Chen, B. B., Nadakal, S., Highsmith, K. & 15 others, Ouahes, T., Conteh, S., Sharma, A., Torano, H., Butler, B., Reiter, K., Rausch, K. M., Scaria, P. V., Anderson, C., Narum, D. L., Salanti, Ali, Fried, M., Theander, Thor Grundtvig, Gamain, B. & Duffy, P. E., 2023, In: Lab Animal. 52, 12, p. 315-323

    Research output: Contribution to journal › Journal article › Research › peer-review

  6. Published

    A Virus-like Particle-Based F4 Enterotoxigenic Escherichia coli Vaccine Is Inhibited by Maternally Derived Antibodies in Piglets but Generates Robust Responses in Sows

    Aves, Kara-Lee, Guerra, Priscila Regina, Fresno, A. H., Saraiva, M. M. S., Cox, E., Bækbo, P. J., Nielsen, Morten Agertoug, Sander, Adam F. & Olsen, John Elmerdahl, 2023, In: Pathogens. 12, 12, 19 p., 1388.

    Research output: Contribution to journal › Journal article › Research › peer-review

  7. Published

    A cVLP-based vaccine displaying full-length PCSK9 elicits a higher reduction in plasma PCSK9 than similar peptide-based cVLP vaccines

    Goksøyr, L., Skrzypczak, M., Sampson, M., Nielsen, Morten Agertoug, Salanti, Ali, Theander, Thor Grundtvig, Remaley, A. T., Jongh, W. A. D. & Sander, Adam F. , 2023, In: Vaccines. 11, 1, 2.

    Research output: Contribution to journal › Journal article › Research › peer-review

  8. Published

    Bispecific T cell-engager targeting oncofetal chondroitin sulfate induces complete tumor regression and protective immune memory in mice

    Skeltved, Nanna, Nordmaj, Mie Anemone, Pagh-Berendtsen, Nicolai, Dagil, Robert, Stormer, E. M. R., Al-Nakouzi, N., Jiang, K., Aicher, A., Heeschen, C., Gustavsson, Tobias, Choudhary, Swati, Gögenur, Ismail, Christensen, Jan Pravsgaard, Theander, Thor Grundtvig, Daugaard, M., Salanti, Ali & Nielsen, Morten Agertoug, 2023, In: Journal of Experimental & Clinical Cancer Research. 42, 16 p., 106.

    Research output: Contribution to journal › Journal article › Research › peer-review

  9. Published

    Comparative analysis of spike-specific IgG Fc glycoprofiles elicited by adenoviral, mRNA, and protein-based SARS-CoV-2 vaccines

    Van Coillie, J., Pongracz, T., Šuštić, T., Wang, W., Nouta, J., Le Gars, M., Keijzer, S., Linty, F., Cristianawati, O., Keijser, J. B. D., Visser, R., van Vught, L. A., Slim, M. A., van Mourik, N., Smit, M. J., Sander, A., Schmidt, D. E., Steenhuis, M., Rispens, T., Nielsen, M. A. & 31 others, Mordmüller, B. G., Vlaar, A. P. J., Ellen van der Schoot, C., Roozendaal, R., Wuhrer, M., Vidarsson, G., Appelman, B., van de Beek, D., Bomers, M. K., de Brabander, J., Brouwer, M. C., Buis, D. T. P., Chekrouni, N., van Gils, M. J., de Jong, M. D., Lavell, A. H. A., Olie, S. E., Peters, E. J. G., Reijnders, T. D. Y., Schinkel, M., Schuurman, A. R., Sikkens, J. J., Smulders, Y. M., Wiersinga, J. W., Spinello, A., Bassoli, C., Bestetti, G., Corbellino, M., Salanti, Ali, Theander, Thor Grundtvig & in collaboration with the UMC COVID-19 S3/HCW study group, I. C. W. T. U. C. S. S. G., 2023, In: iScience. 26, 9, p. 1-15 107619.

    Research output: Contribution to journal › Journal article › Research › peer-review

  10. Published

    First-in-human use of a modular capsid virus-like vaccine platform: An open-label, non-randomised, phase 1 clinical trial of the SARS-CoV-2 vaccine ABNCoV2

    Smit, M. J., Sander, A. F., Ariaans, M. B. P. A., Fougeroux, C., Heinzel, C., Fendel, R., Esen, M., Kremsner, P. G., Ter Heine, R., Wertheim, H. F., Idorn, M., Paludan, S. R., Underwood, A. P., Binderup, A., Ramirez, S., Bukh, J., Soegaard, M., Erdogan, S. M., Gustavsson, T., Clemmensen, S. & 14 others, Theander, Thor Grundtvig, Salanti, Ali, Hamborg, M., de Jongh, W. A., McCall, M. B. B., Nielsen, Morten Agertoug, Mordmüller, B. G., COUGH-1 trial study group, C. T. S. G., Dagil, Robert, Goksøyr, L., Hulen, T. M., Brygger, C. M. J., Khalifé, P. K. & Vidal-Calvo, Elena Ethel, 2023, In: The Lancet Microbe. 4, 3, p. e140-e148

    Research output: Contribution to journal › Journal article › Research › peer-review

  11. 2022
  12. Published

    A capsid virus-like particle-based SARS-CoV-2 vaccine induces high levels of antibodies and protects Rhesus macaques

    Volkmann, A., Koopman, G., Mooij, P., Verschoor, E. J., Verstrepen, B. E., Bogers, W. M. J. M., Idorn, M., Paludan, S. R., Vang, S., Nielsen, Morten Agertoug, Sander, Adam F. , Schmittwolf, C., Hochrein, H. & Chaplin, P., 2022, In: Frontiers in Immunology. 13, p. 857440

    Research output: Contribution to journal › Journal article › Research › peer-review

  13. Published

    An S1-Nanoparticle Vaccine Protects against SARS-CoV-2 Challenge in K18-hACE2 Mice

    van Oosten, L., Yan, K., Rawle, D. J., Le, T. T., Altenburg, J. J., Fougeroux, Cyrielle Elyette, Goksøyr, L., de Jongh, W. A., Nielsen, Morten Agertoug, Sander, Adam F. , Pijlman, G. P. & Suhrbier, A., 2022, In: Journal of Virology. 96, 14, 00844-22.

    Research output: Contribution to journal › Letter › Research › peer-review

Previous 1 2 3 4 5 6 7 8 ...10 Next

ID: 3145601